医用液体粘合剂固定颈静脉中心静脉导管敷料预防ICU敷料失败(STICKY试验):一项随机对照试验
STICKY试验为多中心平行组优势随机对照试验,纳入澳大利亚4个城市ICU中年龄≥18岁、颈静脉CVC置入12小时内、预计需CVC≥72小时且留ICU≥24小时的患者160例(对照组82例,干预组78例)。干预组在标准CVC敷料边缘下皮肤涂抹医用液体粘合剂(MLA),对照组仅用标准CVC敷料。主要终点7天内因边缘翘起导致的敷料失败在干预组为28%(22/78)、对照组为50%(41/82),OR 0.39(95%CI 0.20-0.76,p=0.005),干预组敷料更换次数更少(IRR 0.74,95%CI 0.55-0.99);敷料失败时间(log-rank检验 p=0.12)和全因CVC失败(IRR 1.44,95%CI 0.36-5.79)两组无差异。作者认为MLA应被考虑用于ICU中保护颈静脉CVC敷料。
要点
- ICU颈静脉CVC患者使用MLA涂抹于敷料边缘下皮肤,7天内敷料过早失败率28%(22/78)vs 对照组50%(41/82),OR 0.39(95%CI 0.20-0.76,p=0.005)。
- 干预组敷料更换次数更少,IRR 0.74(95%CI 0.55-0.99)。
- 敷料失败时间(log-rank检验 p=0.12)与全因CVC失败(IRR 1.44,95%CI 0.36-5.79)两组无差异。
- 皮肤损伤共3例:干预组1例(水疱),对照组2例(浸渍和皮肤撕裂)。
- 作者认为MLA应被考虑用于ICU中保护颈静脉CVC敷料。
适用人群与场景
- 年龄≥18岁、颈静脉CVC置入12小时内、预计需要CVC≥72小时且预计留ICU≥24小时的ICU患者。
处置流程与药物剂量
- 干预组:在标准CVC敷料边缘下皮肤涂抹医用液体粘合剂(MLA),再覆盖标准CVC敷料。
- 对照组:仅使用标准CVC敷料。
研究设计与关键结果
- 多中心平行组优势随机对照试验,纳入澳大利亚4个城市ICU的160例患者(对照组82例,干预组78例),按医院和性别分层随机。
- 主要终点7天内因边缘翘起导致的敷料失败:干预组22例(28%)vs 对照组41例(50%),OR 0.39(95%CI 0.20-0.76,p=0.005)。
- 敷料更换总次数:干预组少于对照组,IRR 0.74(95%CI 0.55-0.99)。
- 敷料失败时间:两组无差异(log-rank检验 p=0.12)。
- 全因CVC失败:两组无差异,IRR 1.44(95%CI 0.36-5.79)。
- 皮肤损伤:共3例,干预组1例(水疱),对照组2例(浸渍和皮肤撕裂)。
证据类型、等级与局限
- 证据类型:多中心平行组优势随机对照试验(RCT)。
- 作者结论:MLA与颈静脉CVC敷料失败显著减少和敷料留置时间延长相关,安全性可接受;作者认为MLA应被考虑用于ICU中保护颈静脉CVC敷料。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对于ICU中颈静脉CVC患者,作者认为MLA应被考虑用于保护敷料,可减少7天内敷料过早失败并减少敷料更换次数;但全因CVC失败无差异,且需注意皮肤损伤(干预组1例水疱)。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Central venous catheters (CVCs) are vital for treating ICU patients. However, up to a quarter of CVCs fail from mechanical or infective complications. Poor securement of CVCs to the skin contributes to catheter failure, particularly CVCs placed in the jugular vein, which are highly vulnerable to pullout forces. This study evaluated the effectiveness of medical liquid adhesive (MLA) for improving jugular CVC dressing adhesion.
DESIGN: Multisite parallel group, superiority, randomized controlled trial.
SETTING: Four metropolitan Australian ICUs.
PATIENTS: Eligible patients were 18 years old or older, within 12 hours of jugular CVC insertion, expected to need the CVC for greater than or equal to 72 hours, and remain in ICU for greater than or equal to 24 hours.
INTERVENTIONS: Patients were randomly allocated (stratified by hospital and gender) to standard CVC dressings with the application of MLA to skin under the dressing border (intervention) or standard care CVC dressings (control).
MEASUREMENTS AND MAIN RESULTS: The primary endpoint was dressing failure within 7 days due to lifting edges. Secondary outcomes included the total number of dressing changes, skin injury, and CVC failure. In total, 160 participants (82 control; 78 intervention) were enrolled. There were 22 (28%) and 41 (50%) cases of premature dressing failure in the intervention and control groups respectively (odds ratio, 0.39; 95% CI, 0.20-0.76; p = 0.005). The intervention group had fewer dressing changes (incidence rate ratio [IRR], 0.74; 95% CI, 0.55-0.99). Time to dressing failure (log-rank test; p = 0.12) and all-cause CVC failure (IRR, 1.44; 95% CI, 0.36-5.79) did not differ between groups. Three skin injuries occurred: one in the intervention (blister) and two in the control (maceration and skin tear) groups.
CONCLUSIONS: MLA is associated with significantly decreased jugular CVC dressing failure and longer dressing dwell, with an acceptable safety profile. MLA should be considered to preserve jugular CVC dressings in ICU.
参考来源
- Marsh N, O'Brien C, Larsen EN, et al. Securing Jugular Central Venous Catheters With Dressings Fixed to a Liquid Adhesive to Prevent Dressing Failure in Intensive Care Patients (the STICKY Trial): A Randomized Controlled Trial. Crit Care Med. 2025. PMID: 39982180. doi:10.1097/CCM.0000000000006533
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。